Boreal Biomanufacturing
Ottawa, ON · Canada
Specialization: Early-phase cell and viral vector CDMO
Key Differentiator
Non-profit early-phase CDMO that has made more than 20 cell and virus-based products for human trials.
Core Services
Process and assay development; Phase I-III GMP manufacturing; QC and analytical testing; Cell therapy manufacturing; Viral vector and oncolytic virus manufacturing
Capabilities
Market Intelligence
Formerly The Ottawa Hospital Biotherapeutics Manufacturing Centre (BMC), opened in 2006 and renamed Boreal in June 2026. Based on The Ottawa Hospital General Campus, with a planned 2029 move to the University of Ottawa Advanced Medical Research Centre.
Website
https://boreal-bio.comSimilar Companies
AGC Biologics
Bothell, WA (US HQ); Boulder, CO; Longmont, CO ·
Proprietary CHEF1® expression system
ARSI Canada Inc.
Mississauga, ON (Unit 16, 6800 Kitimat Rd) · Custom synthesis, analytical development, drug development
Mississauga CRO
Actylis (Montreal Operations)
Quebec ·
Global API and excipient supplier with Canadian manufacturing
Ajinomoto Bio-Pharma Services
San Diego, CA; Oss, Netherlands ·
Proprietary AJICAP™ site-specific ADC bioconjugation technology
Need help finding the right outsourcing partner?
Try AI NavigatorCompany information is sourced from publicly available data and may not be current. PharmoniQ does not endorse any company listed. Contact companies directly for the most up-to-date information.